SAVE THE DATE:
You and your nurse practitioner colleagues are invited to
An AANP 2023 Satellite Symposium on
The Evidence and Role of Sensor-Based Continuous Glucose Monitoring, (CGM) for Improving Patient Care and Satisfaction in Persons with Type 2 Diabetes:
Practical Action Steps for Establishing CGM-Based Care at the Front Lines of Primary Practice
An Interactive Case Management and Data-Driven 2023
Technology and Practice Update for the Nurse Practitioner
Save the Date and Time – Register Now!
5:00 PM – 6:15 PM
Ernest N. Morial Convention Center
Room 243-245
New Orleans, LA
Friday, June 23, 2023 | 5:00 PM — 6:15 PM
Program Agenda
5:00 PM – 5:15 PM
Program Chairperson’s Introduction
The Foundational Importance of Sensor-Based CGM in the Primary Provider Setting
New Guidelines Provide a Roadmap for Better Readouts and Better Outcome
Celia Levesque, RN, MSN, CNS-BC, NP-C, CDE, BC-ADM
Program Chair | Advanced Practice Registered Nurse | Endocrine Neoplasia and Hormonal Disorders | MD Anderson Cancer Center | Houston, TX
5:15 PM – 5:35 PM
An Evolving Standard for Optimizing Quality of Diabetes Care: How Do Ambulatory Glucose Profiles (AGP) and Glucose Profile Insight Reports (GPIR) Improve Diabetes Management, Clinical Outcomes, and Provider Interventions in Persons with T2D?
Focus on Practical Steps, GPIR/AGP Interpretation, and Therapeutic Interventions Guided by CGM Readouts
Jennifer Goldman, PharmD, CDCES, BC‑ADM, FCCP
Professor of Pharmacy Practice | linical Pharmacist | Well Life Massachusetts College of Pharmacy and Heath Sciences | Boston, MA
5:35 PM – 5:55 PM
Maximizing Patient Engagement and Satisfaction with Sensor-Based Glucose Monitoring
New Real-World Data Confirming Patient-Centric Preferences for CGM-Based Care in the Primary Provider Setting
Jennifer Goldman, PharmD, CDCES, BC‑ADM, FCCP
Professor of Pharmacy Practice | linical Pharmacist | Well Life Massachusetts College of Pharmacy and Heath Sciences | Boston, MA
5:55 PM – 6:15 PM
Audience-Faculty Interactive Patient Management Sessions: Putting CGM Into Practice in the Real World
Using Individualized AGP/GPIR Reports and Glycemic Metrics to Move Beyond HbA1c to Optimize Health Outcomes in Diabetes
Jennifer Goldman, PharmD, CDCES, BC‑ADM, FCCP
Professor of Pharmacy Practice | linical Pharmacist | Well Life Massachusetts College of Pharmacy and Heath Sciences | Boston, MA
Program Chair and Faculty
Celia Levesque, RN, MSN, CNS-BC, NP-C, CDE, BC-ADM
– Program Chair
Program Chair
Advanced Practice Registered Nurse
Endocrine Neoplasia and Hormonal Disorders
MD Anderson Cancer Center
Houston, TX
Jennifer Goldman, PharmD, CDCES, BC‑ADM, FCCP
Professor of Pharmacy Practice, Clinical Pharmacist, Well Life
Massachusetts College of Pharmacy and Heath Sciences
Boston, MA
EDUCATIONAL AND LEARNING OBJECTIVES
Upon completion of this activity, participants will be able to:
- Explain how sensor-based glucose monitoring can be used to improve health metrics in persons with diabetes and obesity
- Describe new device-based advances in CGM technology, including how to use Glucose Pattern Insight Reports (GPIR) to guide both patient-based behavioral change and clinician-directed interventions in persons with diabetes
- Discuss the critical importance of continuous glucose monitoring to ensure attainment of glycemic targets—TIR, GV, and HA1c/GMI—in obese patients with Type 2 diabetes, regardless of therapeutic interventions used to lower blood glucose
- Identify the processes, triggers, and authorization protocols for reimbursement for technologies/devices used for continuous glucose monitoring
- Illustrate the practice efficiencies and patient education/behavior guidance dimensions of using the Glucose Patterns Insight Report available on some CGM devices
- Identify a broad range of persons with Type 2 diabetes, including those on oral therapies for obesity, who can potentially benefit from flash continuous monitoring
- Establish protocols and clinical decision trees for incorporating and implementing sensor-based CGM within the management workflow for diabetes care in the physician associate and primary care settings
TARGET AUDIENCE — WHO SHOULD ATTEND
This Clinical Excellence Summit is directed at the following: nurse practitioners, physician associates, diabetes and endocrinology specialists and researchers and related healthcare providers who manage patients with Type 2 or Type 1 diabetes.
GRANTOR SUPPORT
Supported by an educational grant from Abbott Diabetes Care.
———